KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

LifeMD (LFMD) Other Operating Expenses (2016 - 2025)

LifeMD filings provide 11 years of Other Operating Expenses readings, the most recent being -$24.5 million for Q4 2025.

  • On a quarterly basis, Other Operating Expenses fell 160.32% to -$24.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $61.5 million, a 12.6% decrease, with the full-year FY2025 number at $76.7 million, up 24.94% from a year prior.
  • Other Operating Expenses hit -$24.5 million in Q4 2025 for LifeMD, down from $33.9 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $33.9 million in Q3 2025 to a low of -$24.5 million in Q4 2025.
  • Median Other Operating Expenses over the past 5 years was $23.6 million (2021), compared with a mean of $18.1 million.
  • Biggest five-year swings in Other Operating Expenses: surged 9577.9% in 2023 and later crashed 160.32% in 2025.
  • LifeMD's Other Operating Expenses stood at $23.9 million in 2021, then rose by 1.17% to $24.2 million in 2022, then dropped by 0.4% to $24.1 million in 2023, then tumbled by 139.06% to -$9.4 million in 2024, then plummeted by 160.32% to -$24.5 million in 2025.
  • The last three reported values for Other Operating Expenses were -$24.5 million (Q4 2025), $33.9 million (Q3 2025), and $24.5 million (Q2 2025) per Business Quant data.